Close
Top Videos
Top Searches
Moods
Black Lives Matter
Chill
Christmas
Commute
Energy boosters
Feel-Good
Focus
Party
Pride
Romance
Sad
Sleep
Workout
Genres
African
Arabic
Blues
Bollywood & Indian
Christian & Gospel
Classical
Country and Americana
Dance and electronic
Decades
Family
Folk and acoustic
Hip-hop
Indie and alternative
J-Pop
Jazz
K-Pop
Latin
Mandopop & Cantopop
Metal
Pop
R&B and Soul
Reggae and Caribbean
Rock
Soundtracks and musicals
The tests that are needed to make a definitive diagnosis of CLL
02:58
|
Download MP3
Related Videos
5:11
iStopMM: the psychological effects of MGUS screening and changes to clinical presentation of myeloma
3:08
Welcome to the Video Journal of Hematology & Hematological Oncology 🎥🩸
5:21
Challenges in the treatment and management of ET and the need to improve therapeutic approaches
1:31
Frontline treatment for CLL: the changing paradigm
2:13
Personalizing the timing of SCT in patients with myelofibrosis
0:44
Early detection and interception across hematological cancers
5:40
Recommendations for biomarker analysis in CLL: updates from ERIC 2024
6:54
Biomarker-guided treatment of CLL in the chemo-free era
3:48
Trials of interest in newly diagnosed myeloma presented at IMS 2024
3:02
The role of asparaginase in the treatment of ALL
2:06
Introducing molecular diagnostics to improve leukemia care in developing countries
1:15
The diagnosis and management of MDS/MPN with neutrophilia (atypical CML)
3:40
Master class in transplantation and hematology: highlights
2:17
Key challenges in treating patients with t(11;14) multiple myeloma with BCL2 inhibitors
3:11
Defining and identifying ultra-high-risk multiple myeloma
1:23
The cardiac rhythm in thalassemia: increased incidence of atrial fibrillation and stroke
3:22
Advances and unanswered questions in AML: novel agents, MRD assessment, and immunotherapy
1:42
The future of CLL treatment: aiming for long-lasting remission
1:22
Responses to olutasidenib in patients with AML who have failed treatment with venetoclax
0:44
Predictors of poor response to azacitidine, venetoclax, and magrolimab in TP53-mutated AML
5:11 3:08 5:21 1:31 2:13 0:44 5:40 6:54 3:48 3:02 2:06 1:15 3:40 2:17 3:11 1:23 3:22 1:42 1:22 0:44
